Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00220194
Status:
COMPLETED
Last Update Posted:
2016-10-14
First Post:
2005-09-17
Brief Title:
A Six-Month Open-Label Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 225 Mg And Eligard 225 Mg Or Zoladex 108 Mg And Eligard 225 Mg In Patients With Advanced Prostate Cancer
Sponsor:
San Bernardino Urological Associates Medical Group Inc
Organization:
San Bernardino Urological Associates Medical Group Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-04
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2005-06
Completion Date Type:
None
First Submit Date:
2005-09-17
First Submit QC Date:
September 17 2005
Study First Post Date:
2005-09-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-10-13
Last Update Post Date:
2016-10-14
Last Update Post Date Type:
ESTIMATED